| 000 | 01901 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514160754.0 | ||
| 264 | 0 | _c20031203 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a0021-9525 | ||
| 024 | 7 |
_a10.1083/jcb.200304159 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDebnath, Jayanta | |
| 245 | 0 | 0 |
_aAkt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. _h[electronic resource] |
| 260 |
_bThe Journal of cell biology _cOct 2003 |
||
| 300 |
_a315-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBreast _xcytology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 |
_aCell Polarity _xdrug effects |
| 650 | 0 | 4 |
_aCell Size _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCyclin D1 _xmetabolism |
| 650 | 0 | 4 |
_aDNA _xanalysis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEpithelial Cells _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMorphogenesis _xdrug effects |
| 650 | 0 | 4 | _aProtein Kinase Inhibitors |
| 650 | 0 | 4 |
_aProtein Kinases _xdrug effects |
| 650 | 0 | 4 | _aProtein Serine-Threonine Kinases |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
| 650 | 0 | 4 |
_aRetroviridae _xgenetics |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
| 700 | 1 | _aWalker, Stephanie J | |
| 700 | 1 | _aBrugge, Joan S | |
| 773 | 0 |
_tThe Journal of cell biology _gvol. 163 _gno. 2 _gp. 315-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1083/jcb.200304159 _zAvailable from publisher's website |
| 999 |
_c14311557 _d14311557 |
||